Cargando…

Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3

An important drawback in the management of glioblastoma (GBM) patients is the frequent relapse upon surgery and therapy. A likely explanation is that conventional therapies poorly affect a small population of stem-like cancer cells (glioblastoma stem cells, GSCs) that remain capable of repopulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Carla Lucia, Nuzzo, Silvia, Ibba, Maria Luigia, Ricci-Vitiani, Lucia, Pallini, Roberto, Condorelli, Gerolama, Catuogno, Silvia, de Franciscis, Vittorio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352497/ https://www.ncbi.nlm.nih.gov/pubmed/32486489 http://dx.doi.org/10.3390/cancers12061434

Ejemplares similares

The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
por: Affinito, Alessandra, et al.
Publicado: (2019)

Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
por: Esposito, Carla Lucia, et al.
Publicado: (2018)

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017)

Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
por: Affinito, Alessandra, et al.
Publicado: (2020)

Targeting Insulin Receptor with a Novel Internalizing Aptamer
por: Iaboni, Margherita, et al.
Publicado: (2016)

Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
por: Esposito, Carla Lucia, et al.
Publicado: (2021)

Recent Advance in Biosensors for microRNAs Detection in Cancer
por: Catuogno, Silvia, et al.
Publicado: (2011)

Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells
por: Esposito, Carla Lucia, et al.
Publicado: (2014)

RYK promotes the stemness of glioblastoma cells via the WNT/β-catenin pathway
por: Adamo, Assunta, et al.
Publicado: (2017)

A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
por: Esposito, Carla Lucia, et al.
Publicado: (2011)

Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
por: Catuogno, Silvia, et al.
Publicado: (2018)

An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
por: Catuogno, Silvia, et al.
Publicado: (2019)

The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses
por: Ciccone, Giuseppe, et al.
Publicado: (2023)

Coupling Aptamers to Short Interfering RNAs as Therapeutics
por: Cerchia, Laura, et al.
Publicado: (2011)

Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
por: Catuogno, Silvia, et al.
Publicado: (2016)

Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response
por: Matteoni, Silvia, et al.
Publicado: (2021)

Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression
por: Papale, Marco, et al.
Publicado: (2020)

Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
por: Russo, Valentina, et al.
Publicado: (2018)

Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like Cells
por: Dini, Valentina, et al.
Publicado: (2023)

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021)

The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature
por: Nuzzo, Silvia, et al.
Publicado: (2020)

Predicting Survival in Glioblastoma Patients Using Diffusion MR Imaging Metrics—A Systematic Review
por: Brancato, Valentina, et al.
Publicado: (2020)

Aptamer Cell-Based Selection: Overview and Advances
por: Catuogno, Silvia, et al.
Publicado: (2017)

TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients
por: Morelli, Maria Beatrice, et al.
Publicado: (2022)

Selection of RNA aptamers targeting hypoxia in cancer
por: Nuzzo, Silvia, et al.
Publicado: (2022)

Characterization of Glioblastoma Cells Response to Regorafenib
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2022)

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
por: Iaboni, Margherita, et al.
Publicado: (2016)

Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation
por: Esposito, Carla L., et al.
Publicado: (2023)

Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
por: Tentori, Lucio, et al.
Publicado: (2014)

Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments
por: Iannolo, Gioacchin, et al.
Publicado: (2019)

Nucleic Acids in Human Glioma Treatment: Innovative Approaches and Recent Results
por: Catuogno, S., et al.
Publicado: (2012)

Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome
por: Cesarini, Valeriana, et al.
Publicado: (2017)

Trends and challenges in modeling glioma using 3D human brain organoids
por: Mariappan, Aruljothi, et al.
Publicado: (2020)

Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells
por: Ziberi, Sihana, et al.
Publicado: (2019)

Emerging Therapeutic RNAs for the Targeting of Cancer Associated Fibroblasts
por: Santana-Viera, Laura, et al.
Publicado: (2020)

Advances in Oligonucleotide Aptamers for NSCLC Targeting
por: Rotoli, Deborah, et al.
Publicado: (2020)

Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance
por: Buccarelli, Mariachiara, et al.
Publicado: (2022)

Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical Treatments
por: Grande, Sveva, et al.
Publicado: (2022)

Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
por: Ceruti, Tommaso, et al.
Publicado: (2022)

Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression
por: Quirico, Lorena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_msfn4anb4g84hpb8qp4fncpua7